000 03649nam a22005535i 4500
999 _c200457017
_d75229
003 DE-He213
005 20231109085739.0
007 cr nn 008mamaa
008 221025s2022 si | s |||| 0|eng d
020 _a9789811947117
024 7 _a10.1007/978-981-19-4711-7
_2doi
040 _aTR-AnTOB
_beng
_cTR-AnTOB
_erda
060 _aWP 145
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
072 7 _aMJCL
_2thema
096 _aWP145EBK
245 1 0 _aPersonalization in Gynecologic Oncology
_h[electronic resource] /
_cedited by Masaki Mandai.
250 _a1st ed. 2022.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aComprehensive Gynecology and Obstetrics,
_x2364-219X
505 0 _a1 Personalized treatment in ovarian cancer -- 2 Carcinogenesis and personalization in hpv-associated precancer lesions of the cervix -- 3 Personalized treatment for gestational trophoblastic tumor -- 4 Personalized treatment in uterine sarcoma -- 5 Clinical relevance of brca1/2 pathogenic variants and impaired dna repair pathways in ovarian carcinomas -- 6 Personalized treatment in immunotherapy for gynecologic cancer -- 7 Risk assessment and prevention strategies for hereditary gynecological cancers -- 8 How genome-wide analysis contributes to personalized treatment in cancers including gynecologic cancers -- 9 Personalized treatment of gynecological cancer according to age and symptom benefit.
520 _aThis book thoroughly illustrates the designed and tailored medical approaches for tumors of the female reproductive organ. The chapters explore different cancer species such as ovarian cancer, endometrial cancer, cervical cancer, etc. Various treatment modalities such as immunotherapy and histotype-specific treatment are delivered, and it offers a chapter on how genome-wide analysis contributes to personalized treatment. It is essential to understand this concept because many molecular target drugs and the prevalence of genome-based analysis in clinical settings have enabled us to introduce valid precision medicine in the field of gynecologic oncology. Chapters explain the stream of transition from conventional standardized treatment to personalized treatment and address future perspectives. Personalization Gynecologic Oncology is a well-designed source for beginning to advanced oncologists, gynecologists, geneticists, genetic counselors, and nurses. Offering the latest treatment strategies, the Editor hopes the ideas presented here will be a foundation for further development in the field. .
650 0 _aOncology.
650 0 _aGynecology .
650 0 _aCancer
_xGenetic aspects.
650 0 _aTumor markers.
650 1 4 _aOncology.
650 2 4 _aGynecology.
650 2 4 _aCancer Genetics and Genomics.
650 2 4 _aTumour Biomarkers.
653 0 _aGenital Neoplasms, Female -- therapy
653 0 _aPrecision Medicine -- methods
700 1 _aMandai, Masaki.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
830 0 _aComprehensive Gynecology and Obstetrics,
_x2364-219X
856 4 0 _uhttps://doi.org/10.1007/978-981-19-4711-7
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng